FY2016 Earnings Estimate for Humana Inc. (HUM) Issued By Jefferies Group
Humana Inc. (NYSE:HUM) – Equities researchers at Jefferies Group upped their FY2016 earnings estimates for Humana in a note issued to investors on Thursday. Jefferies Group analyst D. Windley now anticipates that the brokerage will post earnings of $9.51 per share for the year, up from their previous forecast of $9.28. Jefferies Group currently has a “Buy” rating and a $217.00 target price on the stock. Jefferies Group also issued estimates for Humana’s FY2017 earnings at $11.40 EPS and FY2018 earnings at $11.51 EPS.
Several other research analysts also recently commented on HUM. Cantor Fitzgerald reissued a “buy” rating on shares of Humana in a report on Saturday, July 9th. RBC Capital Markets reaffirmed a “buy” rating and set a $224.00 price objective (up previously from $220.00) on shares of Humana in a report on Friday, July 22nd. Royal Bank Of Canada reduced their price objective on Humana from $222.00 to $217.00 and set a “sector perform” rating on the stock in a report on Thursday. Susquehanna reaffirmed a “neutral” rating and set a $180.00 price objective on shares of Humana in a report on Thursday. Finally, Barclays PLC reduced their price objective on Humana from $193.00 to $191.00 and set an “equal weight” rating on the stock in a report on Thursday, August 4th. Seven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $200.50.
Shares of Humana (NYSE:HUM) opened at 170.82 on Monday. The stock has a 50 day moving average price of $175.94 and a 200 day moving average price of $175.74. The firm has a market cap of $25.46 billion, a PE ratio of 26.24 and a beta of 0.90. Humana has a 12 month low of $150.00 and a 12 month high of $191.65.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/17/fy2016-earnings-estimate-for-humana-inc-hum-issued-by-jefferies-group.html
Humana (NYSE:HUM) last issued its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.23 by $0.07. The business earned $14 billion during the quarter, compared to analysts’ expectations of $13.59 billion. Humana had a return on equity of 11.11% and a net margin of 1.76%. Humana’s revenue was up 2.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.67 earnings per share.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be given a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date of this dividend is Tuesday, October 11th. Humana’s dividend payout ratio is currently 18.18%.
Several hedge funds have recently added to or reduced their stakes in HUM. Renaissance Technologies LLC boosted its stake in Humana by 246.3% in the first quarter. Renaissance Technologies LLC now owns 446,000 shares of the insurance provider’s stock worth $81,596,000 after buying an additional 317,200 shares in the last quarter. Prudential PLC raised its position in shares of Humana by 3.0% in the first quarter. Prudential PLC now owns 8,866 shares of the insurance provider’s stock worth $1,622,000 after buying an additional 259 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Humana by 2.3% in the first quarter. Geode Capital Management LLC now owns 1,166,562 shares of the insurance provider’s stock worth $212,975,000 after buying an additional 25,947 shares during the last quarter. Loomis Sayles & Co. L P raised its position in shares of Humana by 52.6% in the first quarter. Loomis Sayles & Co. L P now owns 300,004 shares of the insurance provider’s stock worth $54,886,000 after buying an additional 103,370 shares during the last quarter. Finally, Nicholas Investment Partners LP raised its position in shares of Humana by 45.1% in the first quarter. Nicholas Investment Partners LP now owns 6,983 shares of the insurance provider’s stock worth $1,278,000 after buying an additional 2,170 shares during the last quarter. Institutional investors and hedge funds own 93.27% of the company’s stock.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.